Sanara MedTech Q4 net revenue up 49% to $26.3M; net loss widens to $1.7M

Sanara MedTech Inc.

Q4 net revenue $26.3M (+49% YoY); full year $86.7M (+33% YoY).
Q4 net loss $1.7M vs $0.3M loss prior year; full year net loss $9.9M vs $4.4M.
Adjusted EBITDA Q4 $0.9M (vs $0.4M); full year $2.7M (vs $0.1M).
Sanara Surgical Q4 net income $0.9M; Tissue Health Plus segment loss $2.6M on platform buildout.
Exclusive license & distribution deal with BMI for OsStic bone void filler; term loan amended for additional borrowings.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.